• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

PRTX:US

7.9000 USD 0.2900 3.54%

As of 20:10:00 ET on 07/31/2014.

Snapshot for Protalex Inc (PRTX)

Open: 8.0000 Day's Range: 7.9000 - 8.0000 Volume: 310
Previous Close: 8.1900 52wk Range: 1.3000 - 10.0000 1-Yr Rtn: +97.50%

Stock Chart for PRTX

No chart data available.
  • PRTX:US 7.9000
  • 1D
  • 1M
  • 1Y
8.1900
Interactive PRTX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PRTX

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -0.4100
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 227.26
Shares Outstanding (M) 28.77
30 Day Average Volume 1,616
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/29/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PRTX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for PRTX

Protalex, Inc. develops and markets biopharmaceutical drugs. The Company produces drugs for treating autoimmune and inflammatory diseases including rheumatoid arthritis.

Arnold P KlingPresidentKirk M WarshawCFO/Secretary
Richard J FrancovitchVP:ITP Programs
More Company Profile & Key Executives for PRTX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil